Patent ID: 8067446

Claim:
A method for treating a stomach or small intestine ulcer, comprising administering an effective amount of at least one non-purine xanthine oxidase inhibitor or a salt thereof to a patient in need thereof, wherein said non-purine xanthine oxidase inhibitor is selected from the group consisting of 2-(2-cyanobiphenyl-4-yl)isonicotinic acid; 5-(2-cyanobiphenyl-4-yl)thiophene-2-carboxylic acid; 2-(2-cyanobiphenyl-4-yl)-4-methyl-1,3-thiazole-5-carboxylic acid; 2-(2-cyano-4′-methoxybiphenyl-4-yl)-4-methyl-1,3-thiazole-5-carboxylic acid; 1-(2-cyanobiphenyl-4-yl)-1H-pyrazole-4-carboxylic acid; 1-(2-cyano-4′-methoxybiphenyl-4-yl)-1H-pyrazole-4-carboxylic acid; 2-(2-cyanobiphenyl-4-yl)-1,3-thiazole-5-carboxylic acid; 2-[2-cyano-4′-(trifluoromethoxy)biphenyl-4-yl]-4-methyl-1,3-thiazole-5-carboxylic acid; 2-(2-cyano-3′-methoxybiphenyl-4-yl)-4-methyl-1,3-thiazole-5-carboxylic acid; and 2-[2-cyano-4′-(dimethylamino)biphenyl-4-yl]-4-methyl-1,3-thiazole-5-carboxylic acid.